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Abstract
Esophageal adenoid cystic carcinoma (EACC) is a very rare form of malignant tumor in the esophagus. Here, we
report the case of a 78-year-old man who was diagnosed with EACC by preoperative endoscopic biopsy.
Thoracoscopy-assisted subtotal esophagectomy with lymph node dissection was carried out. Microscopic
examination of the resected specimen suggested that the tumor invaded to submucosal layer and showed no
lymph node metastasis. Histologically, tumor primarily exhibited an alveolar solid pattern with partial cribriform and
tubular patterns. Alcian blue staining showed many mucoid materials within the glandular cavity formed by tumor
cells. Immunohistochemical studies revealed that the tumor cells reacted with pan-cytokeratin immunostains and
expressed vimentin and S-100 protein. Collectively, the tumor was diagnosed as primary EACC, T1bN0M0 according
to “Japanese Classification of Esophageal Cancer 10th edition.” The patient showed no recurrence sign 12 months
after the surgery.
The current study also reviewed 35 EACC cases reported in Japanese literatures from 1990 to 2014. Combined with
our case, we found that EACC is less frequently accompanied by lymph node metastasis as compared to
esophageal squamous cell carcinoma, especially at the early stage. The prognosis of EACC is relatively better when
tumors have no lymph node metastasis.
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Background
Esophageal adenoid cystic carcinoma (EACC) is a rare form
of malignant tumor in the esophagus while relatively com-
mon in the parotid and salivary glands [1, 2]. Histologically,
tumors are well known to consist of two main cell types:
ductal and modified myoepithelial cells, and have three
defined patterns: tubular, cribriform, and solid pattern.
Characteristically, EACC is sometimes accompanied by
squamous cell carcinoma (SCC) and basaloid squamous
cell carcinoma (BSC) components, which can create differ-
ent malignancy as adenoid cystic carcinoma (ACC) of the
parotid and salivary glands. In contrast to these histological
features, little information is available on clinical features
and management because the number of case reports on
EACC is limited. With regard to the prognosis, previous
studies demonstrated conflicting findings: Some studies
explained that, as compared to SCC, frequent lymph node
metastasis and vascular invasion provided patients with
poor prognosis [3, 4]. On the other hand, other studies re-
cently reported that lymph node metastasis occurred less
frequently at the early stage and prognosis was better than
that of SCC. Ishii et al. reported that the average overall
survival of EACC was 25 months when the tumor had no
mixture of SCC or BSC component [5].
Here, we report a case of primary EACC without me-
tastasis that underwent thoracoscopy-assisted subtotal
esophagectomy with lymph node dissection. In addition,
to disclose the clinical features and resolve conflicting
results, we presented a summary of 35 cases of EACC
reported from 1990 to 2014 in Japanese literatures.
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Case presentation
A 78-year-old man was admitted for the treatment of
gastric ulcer in our hospital. He was a heavy smoker with-
out habitual drinking, and presented no lymphadenopathy
in the cervical or supraclavicular regions. Laboratory exam-
ination suggested no remarkable findings, and his serum
levels of carcinoembryonic antigen, carbohydrate antigen
19-9, and squamous cell carcinoma related antigen were
0.8 ng/ml, 9.0 U/ml, and 1.6 ng/ml, respectively.
Endoscopic survey for the follow-up of gastric ulcer
revealed a protruding lesion with smooth surface and
central excavation located in the middle of the esopha-
gus (Fig. 1a). Iodine stain showed unambiguous lightly
stained region (Fig. 1b), which suggested that the tumor
was covered by normal esophageal mucosa. Irregular
patterns of intra-epithelial papillary capillary loops were
found by narrow-band imaging (Fig. 1c), and lesions
with mixed echogenicity in the submucosal layer were
detected by endoscopic ultrasonography (Fig. 1d). Al-
though the results of ordinary biopsy suggested chronic
esophagitis in the mucosa, a boring biopsy at the following
endoscopic survey allowed us to observe a mixture of
cribriform and solid patterns in the tumor component,
which strongly indicated ACC in the esophagus. Com-
puter tomography could not detect any primary lesion in
the esophagus and found no lymph node or distant metas-
tasis. Therefore, under the diagnosis of primary EACC
without metastasis, a thoracoscopy-assisted subtotal esoph-
agectomy with lymph node dissection was carried out,
followed by posterior mediastinal gastroesophagostomy.
The resected tissue specimen showed a non-encapsulated
solid mass with slight erosion, measuring 1.0 × 0.7 cm in
size (Fig. 2a). The cut surface of the tumor demonstrated a
solid mass gray-white appearance mainly located in the
submucosal layer (Fig. 2b). Microscopic examination found
no tumor invasion to the proper muscle layer without
lymph node metastasis (pT1bN0M0 stage I according to
“Japanese Classification of Esophageal Cancer 10th edi-
tion”). An alveolar solid pattern was predominantly shown
(Fig. 3a) while cribriform and tubular patterns were
partially identifiable in the lesion (Fig. 3b). Intraluminal
substance in the tubular pattern regions was stained with
alcian blue and periodic acid-Schiff (PAS) (Fig. 3c, d), which
indicated that the component contained basophilic glycos-
aminoglycans and hyalinized basal lamina material. Immu-
nohistochemistry revealed that the tumor cells reacted with
a b
c d
Fig. 1 Endoscopic findings. a Protruding lesion located in the middle of the esophagus. b The tumor region was faintly stained with iodine.
c Narrow-band imaging of the lesion suggested irregularity of intraepithelial papillary capillary loops. d Endoscopic ultrasonography detected a
mixed echogenic lesion in the submucosal layer
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Fig. 2 Resected tissue specimen. a The solid mass measuring 1.0 × 0.7 cm in size. b Solid mass with graywhite appearance locating mainly in the




Fig. 3 Histological examination. a, b Microscopic examinations showed alveolar solid and cribriform patterns in the resected specimen
(hematoxylin and eosin staining ×40, 200). c PAS and d Alcian blue staining of intraluminal substance in the tubular pattern region (×100).
e–g Immunohistochemical staining with e cytokeratin, f vimentin, and g S-100 protein (×100)
Sawada et al. Surgical Case Reports  (2015) 1:119 Page 3 of 6



















Protruding ACC Surgery SM − − − 2 Alive
1995 74/
M
Elevated ACC Surgery SM − + + 12 Alive
1991 70/
M
Protruding ACC Surgery SM − − + N.A N.A
1995 59/
M
Protruding ACC Surgery SM − − − 13 Alive
2011 67/F Protruding ACC Surgery SM − − − N.A N.A
2012 64/
M
Protruding ACC Surgery SM − − − N.A N.A
2005 81/
M




N.A N.A Surgery SM − N.A N.A 51 Alive
1997 53/
M
Elevated SCC Surgery SM − + + 36 Alive
1994 81/
M
Ulcerative SCC Surgery SM − − − 26 Alive
2001 71/
M
Protruding SCC Surgery SM − − − 41 Alive
2010 60/
M
Protruding SCC NAC + surgery SM − − − 5 Alive
1997 81/
M
N.A N.A Surgery SM − − − 22 Alive
2003 65/
M




Protruding SCC Surgery SM − − − 30 Alive
1992 70/F Protruding N.A Surgery SM − − − 142 Alive
1990 69/
M
Protruding SCC Surgery SM − − − 6 Alive
1990 73/
M
Protruding SCC Surgery SM − − − 18 Alive





MP − + + 56 Alive
2005 68/
M
N.A N.A Surgery MP − N.A N.A 2 Alive
1994 59/
M
Elevated SCC Surgery MP − + − 60 Alive
1991 64/
M
Ulcerative SCC Surgery MP − − − 11 Alive
1992 59/
M
Ulcerative SCC Surgery MP − − + 42 Alive
1996 79/
M
Protruding Adeno Surgery MP − N.A N.A 30 Alive
1994 61/
M
Ulcerative ACC Surgery AD N.A − + 12 Dead (EACC)
2007 51/
M
Ulcerative ACC Surgery AD − − + 2 Alive
1994 Protruding ACC Surgery AD + + + 5
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pan-cytokeratin immunostains (Fig. 3e) and expressed
vimentin and S-100 protein (Fig. 3f, g), collectively support-
ing the pathological diagnosis of primary EACC. The pa-
tient was discharged 63 days after operation, and no sign of
recurrence was detected in the 12 months of follow-up.
Discussion
The incidence of EACC was identified with 0.04 % (1 of
2370 cases) and 0.16 % (4 of 2521 cases) of esophageal
malignant tumors by Igaki et al. [6]. and Hosokawa et al.
[7], respectively. Using Japan Medical Abstracts Society
(http://login.jamas.or.jp/) to search with the keywords
“esophagus” and “adenoid cystic carcinoma”, we found
35 case reports on EACC from 1990 to 2014 (hereafter,
a combination of these cases and our case are referred
to as the reviewed cases) (Table 1). The average age of
the reviewed cases was 66.4 years, and the sex ratio was
30 men to 6 women. The most prevalent tumor appear-
ance in the endoscopic findings was protruded (58.6 %),
and the second was ulcerative (24.1 %). This was consist-
ent with previous reports which concluded that EACC
was derived from esophageal glands, as the tumor was
usually covered by normal mucosa at the early stage and
ulceration was subsequently exhibited as the tumor pro-
gressed [8, 9].
For preoperative diagnosis of EACC, it has so far been
reported that endoscopic biopsy frequently failed to pro-
vide a correct diagnosis of EACC because of its similar
growth pattern like submucosal tumor. In addition, ac-
curate diagnosis may be more challenging when EACC
contained SCC or BSC components [10]. Morisaki et al.
reported that only 8 of 37 cases (21.4 %) in and before
1996 were accurately diagnosed as EACC with endo-
scopic biopsy specimens [11]. In the reviewed cases, cor-
rect diagnosis was shown in 11 of 26 cases (43.2 %)
(diagnosis with biopsy specimen was available for 26 of
36 cases). These results indicated an improvement in
diagnosis accuracy, which was probably made possible
by the development of endoscopic devices such as bor-
ing biopsy and narrow-band imaging system. Another
factor is the establishment of useful markers such as
vimentin and S-100, which help to differentiate EACC
from BSC diagnosis [12, 13].
The average overall survival of the reviewed cases was
27.6 months following clinical diagnosis. At the time of
report, 22 cases were alive while 5 cases died of the
EACC (Table 1). Half of the reviewed cases showed
tumor invasion to the submucosal layer, indicating the
advancement of early EACC detection. Moreover, out of
25 cases with the tumor invading to the submucosal
layer or muscularis propria, only one case showed lymph
node metastasis and no subjects died of the EACC.
These results suggested that early detection of the tumor
provides patients with the possibility of a complete cure.
For treatment, radical resection with regional lymph node
dissection is considered to be the first option, since a sus-
ceptibility for chemotherapy and radiation therapy still
remains elusive [14–16]. In the reviewed cases, 34 cases
underwent radical resection, of which one had neoadju-
vant chemotherapy consisting of low-dose CDDP and 5-
FU, and another one was treated with intensive repeated
combination chemotherapy with CDDP and 5-FU for
1.3 years before surgery. We found only one case that
underwent combination chemotherapy with etoposide
and tegafur for the treatment of liver metastasis of EACC.
Intriguingly, there was a case without metastasis that
received radiation therapy alone and subsequently sur-
vived for 22 months.
In the current case, we were able to apply thoracoscopy-
assisted surgery to this patient because the depth of tumor







N.A N.A Radiation AD - N.A N.A 22 Dead (EACC)
1991 57/
M
Elevated SCC Surgery AD + N.A N.A N.A N.A
1996 68/F Protruding SCC Surgery AD − N.A N.A N.A N.A
1992 64/
M
Elevated N.A Surgery AD + − + 15 Dead (EACC)
1993 77/F Protruding ACC Chemotherapy AI (aorta) + N.A N.A 9 Dead (EACC)
1992 55/
M
Ulcerative SCC Surgery AI
(trachea)
+ + + 7 Dead (EACC)
2005 84/
M
N.A N.A Surgery AI + N.A N.A 40 Alive
1997 70/F Protruding SCC Surgery N.A + N.A N.A 30 Dead
(other disease)
N.A not available, adeno adenocarcinoma, NAC neoadjuvant therapy, SM submucosa, MP muscle, AD adventitia, AI invasion to adjacent organ
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invasion was diagnosed as submucosa before the surgery.
Concomitant with other reviewed cases, our case showed
no lymph node metastasis. We hence expected that the
subsequent prognosis of this patient may be good.
Conclusions
Although the number of the reviewed cases who are ob-
served in a long period is limited, we considered that
prognosis of EACC is relatively better if the tumor is de-
tected with no lymph node metastasis. The incidence of
lymph node metastasis of EACC is less frequent as com-
pared to that of SCC, especially when the tumor invades
to the submucosal layer or muscularis propria. There-
fore, less invasive surgery such as thoracoscopic surgery
may be suitable for EACC at the early stage. Moreover,
previous study reported that a case with EACC in sub-
mucosa was successfully treated by incisional endoscopic
enucleation [17]. For applying the endoscopic treatment
practically, we need large scale study on EACC to make
a sufficient evaluation for the probability of lymph node
metastasis as well as lymphatic and vascular invasion.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
ing images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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